Picture Demy-Colton BioFuture 2024 NYC 3 Biotech Breakthroughs 650x100px
Document › Details

Eppendorf SE. (10/19/21). "Press Release: Eppendorf AG Completes Conversion to European Public Limited Company". Hamburg.

Region Region Hamburg
  Country Germany
Organisations Organisation Eppendorf AG
  Today Eppendorf SE
  Group Eppendorf (Group)
  Organisation 2 Eppendorf SE
  Group Eppendorf (Group)
Products Product laboratory equipment and instruments
  Product 2 consumables, laboratory
Persons Person van Pelt, Eva (Eppendorf 201912– Co-CEO joined 201710 before Leica Microsystems + Hitachi + Siemens)
  Person 2 Fruhstorfer, Peter (Eppendorf 201912– Co-CEO before Head of Business Area Sample Handling)

> Conversion to SE ("Societas Europaea") completed

> No impact on current business

> Group headquarter remains in Hamburg, Germany

The internationally active life science company Eppendorf, headquartered in Hamburg, Germany, has completed its conversion to the European legal form Societas Europaea (SE) as of October 19, 2021. The company will operate as Eppendorf SE with
immediate effect.

"We are convinced that we have taken the right step at the right time with this modern legal form, which is very common in large family-owned companies," said Eva van Pelt and Dr. Peter Fruhstorfer, Co-CEOs of Eppendorf SE. "The company's name as a European public limited company is a clear signal that even more strongly expresses Eppendorf's global corporate culture. In addition, the new legal form shows that Eppendorf is an international company and that national borders play less and less of a role for us."

The new company name as Eppendorf SE demonstrates the company's further development into a modern, progressive, and internationally active European company, the CEOs added. Also, it provides important support that will enable Eppendorf to continue its global success course even more effectively, they said.

The conversion into a Societas Europaea will not result in any changes to the company's structure. Management Board and Supervisory Board members continue to work for Eppendorf SE. Eppendorf's Group headquarters will remain in Hamburg, Germany, and the character of an independent family-owned company will be preserved.

Press contact:

Dr. Ralph Esper
Eppendorf SE
Barkhausenweg 1
22339 Hamburg
Tel.: +49 40 538 01-195
Mobil: +49 170 79 80 778

Simone Hauck
Eppendorf SE
Barkhausenweg 1
22339 Hamburg
Tel.: +49 40 538 01 – 616
Mobil: +49 160 71 34 225

About Eppendorf

Eppendorf is a leading life science company that develops and sells instruments, consumables and services for liquid, sample and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers and DNA amplification equipment as well as ultra-low-temperature freezers, fermentors, bioreactors, CO2 incubators, shakers and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates and single-use bioreactors complement the range of highest-quality premium products.

Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also used in laboratories that perform clinical or environmental analysis, in forensic laboratories and in industrial laboratories where process analysis, production and quality assurance are performed.

Eppendorf was founded in Hamburg, Germany in 1945 and currently has around 4,500 employees worldwide. The company has subsidiaries in 28 countries and is represented in all its other important markets by distributors.

Record changed: 2023-06-05


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Eppendorf (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x300px

» top